Yoon-La Choi
Overview
Explore the profile of Yoon-La Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
327
Citations
7110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park J, Chang E, Kim J, Chelakkot C, Sung M, Song J, et al.
Breast Cancer Res
. 2025 Jan;
27(1):3.
PMID: 39773237
No abstract available.
2.
Seo Y, Yoon Y, Kim H, Seo S, Choi Y, Kim K, et al.
PLoS One
. 2024 Dec;
19(12):e0311300.
PMID: 39637150
Background: To identify the clinical and imaging characteristics of soft tissue sarcomas (STS) of the trunk and extremities that undergo unplanned excision. Methods: This retrospective study evaluated the data of...
3.
Mekonnen N, Yang H, Rajasekaran N, Song K, Choi Y, Shin Y
Transl Oncol
. 2024 Dec;
51:102204.
PMID: 39631207
MYC amplification is disproportionally elevated in triple-negative breast cancer (TNBC) compared to other subtypes of breast cancer. Indeed, MYC has long been considered an undruggable oncogene using conventional drug design...
4.
Kim Y, Lee B, Ha C, Lee C, Jung H, Sun J, et al.
Front Oncol
. 2024 Nov;
14:1463341.
PMID: 39507756
Introduction: Numerous studies have suggested high concordance between tissue and circulating tumor DNA (ctDNA) comprehensive genomic profiling (CGP) tests but only few of them focused on fusions. In addition, atypical...
5.
Kim B, Nam H, Hwang I, Choi Y, Hwang J, Lee H, et al.
Chest
. 2024 Oct;
PMID: 39389342
Background: It remains uncertain for how long pure ground-glass nodules (pGGNs) detected on low-dose CT (LDCT) imaging should be followed up. Further studies with longer follow-up periods are needed to...
6.
Kim H, Kim W, Kim M, Ko N, Jin M, Jung H, et al.
Cancer Immunol Immunother
. 2024 Oct;
73(12):260.
PMID: 39382668
Thyroid immune-related adverse events (irAEs) are associated with programmed cell death protein 1 (PD-1) blockade efficacy in non-small cell lung cancer (NSCLC). However, their independence from PD-L1 expression and quantitative...
7.
Chang E, Song K, Song J, Sung M, Lee M, Oh J, et al.
Cancer Metab
. 2024 Aug;
12(1):25.
PMID: 39210390
Background: Mitochondria are known to synthesize adenosine triphosphate (ATP) through oxidative phosphorylation. Understanding and accurately measuring mitochondrial ATP synthesis rate can provide insights into the functional status of mitochondria and...
8.
Park J, Lee B, Song J, Sung M, Kwon M, Kim C, et al.
Pathology
. 2024 May;
56(5):653-661.
PMID: 38811262
Epidermal growth factor receptor (EGFR) exon 20 insertion mutations (E20ins) are the third most frequent mutations observed in non-small cell lung cancer, accounting for approximately 1-10% of all EGFR mutations....
9.
Kim S, Kim J, Kim T, Park S, Yoon S, Lee S, et al.
BMC Cancer
. 2024 May;
24(1):574.
PMID: 38724991
Background: Next-generation sequencing (NGS) has been introduced to many Korean institutions to support molecular diagnostics in cancer since 2017, when it became eligible for reimbursement by the National Health Insurance...
10.
Kim H, Kim S, Choi S, Park C, Park S, Pereira S, et al.
JCO Precis Oncol
. 2024 May;
8:e2300556.
PMID: 38723233
Purpose: Evaluation of PD-L1 tumor proportion score (TPS) by pathologists has been very impactful but is limited by factors such as intraobserver/interobserver bias and intratumor heterogeneity. We developed an artificial...